- Home
- STVN vs CHYM Comparison
STVN vs CHYM Comparison
Compare STVN & CHYM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- STVN
- CHYM
- Stock Information
- Founded
- STVN 1949
- CHYM 2012
- Country
- STVN Italy
- CHYM United States
- Employees
- STVN N/A
- CHYM N/A
- Industry
- STVN Containers/Packaging
- CHYM Finance: Consumer Services
- Sector
- STVN Consumer Discretionary
- CHYM Finance
- Exchange
- STVN Nasdaq
- CHYM Nasdaq
- Market Cap
- STVN 7.4B
- CHYM 7.0B
- IPO Year
- STVN 2021
- CHYM 2025
- Fundamental
- Price
- STVN $22.87
- CHYM $20.37
- Analyst Decision
- STVN Buy
- CHYM Buy
- Analyst Count
- STVN 4
- CHYM 14
- Target Price
- STVN $25.88
- CHYM $32.85
- AVG Volume (30 Days)
- STVN 360.6K
- CHYM 5.2M
- Earning Date
- STVN 11-06-2025
- CHYM 11-05-2025
- Dividend Yield
- STVN 0.27%
- CHYM N/A
- EPS Growth
- STVN 19.61
- CHYM N/A
- EPS
- STVN 0.60
- CHYM N/A
- Revenue
- STVN $1,373,219,524.00
- CHYM $2,065,624,000.00
- Revenue This Year
- STVN $8.33
- CHYM $31.00
- Revenue Next Year
- STVN $10.12
- CHYM $20.53
- P/E Ratio
- STVN $38.31
- CHYM N/A
- Revenue Growth
- STVN 6.97
- CHYM 61.57
- 52 Week Low
- STVN $17.81
- CHYM $16.17
- 52 Week High
- STVN $28.00
- CHYM $44.94
- Technical
- Relative Strength Index (RSI)
- STVN 45.20
- CHYM N/A
- Support Level
- STVN $20.67
- CHYM N/A
- Resistance Level
- STVN $24.01
- CHYM N/A
- Average True Range (ATR)
- STVN 1.23
- CHYM 0.00
- MACD
- STVN 0.06
- CHYM 0.00
- Stochastic Oscillator
- STVN 45.08
- CHYM 0.00
About STVN Stevanato Group S.p.A.
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
About CHYM Chime Financial Inc. Class A Common Stock
Chime Financial Inc is a financial technology company that believes in core banking services.